Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Recommended Vaccinations for Asplenic and Hyposplenic Adult Patients.

Bonanni P, Grazzini M, Niccolai G, Paolini D, Varone O, Bartoloni A, Filippo B, Santini MG, Baretti S, Bonito C, Zini P, Teresa MM, Fabrizio N, Lea M, Beatrice PM, Boccalini S, Bechini A.

Hum Vaccin Immunother. 2016 Dec 8:0. [Epub ahead of print]

PMID:
27929751
2.

Clinical and economic impact of herpes zoster vaccination in elderly in Italy.

Boccalini S, Alicino C, Martinelli D, Bechini A, Tiscione E, Pellizzari B, Prato R, Icardi G, Iannazzo S, Bonanni P.

Hum Vaccin Immunother. 2016 Dec 7:1-7. doi: 10.1080/21645515.2017.1264832. [Epub ahead of print]

PMID:
27925856
3.

Hospitalizations for pneumonia, invasive diseases and otitis in Tuscany (Italy), 2002-2014: which was the impact of universal pneumococcal pediatric vaccination?

Boccalini S, Varone O, Chellini M, Pieri L, Sala A, Berardi C, Bonanni P, Bechini A.

Hum Vaccin Immunother. 2016 Dec 7:1-7. doi: 10.1080/21645515.2017.1264796. [Epub ahead of print]

PMID:
27925848
4.

Economic studies applied to vaccines against invasive diseases: An updated budget impact analysis of age-based pneumococcal vaccination strategies in the elderly in Italy.

Boccalini S, Bechini A, Gasparini R, Panatto D, Amicizia D, Bonanni P.

Hum Vaccin Immunother. 2016 Dec 7:1-6. doi: 10.1080/21645515.2017.1264827. [Epub ahead of print]

PMID:
27925845
5.

Incidence of herpes zoster and post-herpetic neuralgia in Italy: Results from a three-years population-based study.

Alicino C, Trucchi C, Paganino C, Barberis I, Boccalini S, Martinelli D, Pellizzari B, Bechini A, Orsi A, Bonanni P, Prato R, Iannazzo S, Icardi G.

Hum Vaccin Immunother. 2016 Dec 7:0. [Epub ahead of print]

PMID:
27925843
6.

An eHealth Project on Invasive Pneumococcal Disease: Comprehensive Evaluation of a Promotional Campaign.

Panatto D, Domnich A, Gasparini R, Bonanni P, Icardi G, Amicizia D, Arata L, Carozzo S, Signori A, Bechini A, Boccalini S.

J Med Internet Res. 2016 Dec 2;18(12):e316.

7.

SwiSpot: modeling riboswitches by spotting out switching sequences.

Barsacchi M, Novoa EM, Kellis M, Bechini A.

Bioinformatics. 2016 Nov 1;32(21):3252-3259.

PMID:
27378291
8.

Evaluating the costs and benefits of pneumococcal vaccination in adults.

Porchia BR, Bonanni P, Bechini A, Bonaccorsi G, Boccalini S.

Expert Rev Vaccines. 2017 Feb;16(2):93-107. doi: 10.1080/14760584.2017.1242419.

PMID:
27680425
9.

The role of the general practitioner in the screening and clinical management of chronic viral hepatitis in six EU countries.

Bechini A, Levi M, Falla A, Ahmad A, Veldhuijzen I, Tiscione E, Bonanni P.

J Prev Med Hyg. 2016;57(2):E51-60. Review.

10.

Preparing to introduce the varicella vaccine into the Italian immunisation programme: varicella-related hospitalisations in Tuscany, 2004-2012.

Boccalini S, Bonanni P, Bechini A.

Euro Surveill. 2016 Jun 16;21(24). doi: 10.2807/1560-7917.ES.2016.21.24.30257.

11.

Referral of newly diagnosed chronic hepatitis B and C patients in six EU countries: results of the HEPscreen Project.

Levi M, Falla A, Taddei C, Ahmad A, Veldhuijzen I, Niccolai G, Bechini A.

Eur J Public Health. 2016 Aug;26(4):561-9. doi: 10.1093/eurpub/ckw054.

PMID:
27095794
12.

How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome Chapter Project.

Gasparini R, Mennini FS, Panatto D, Bonanni P, Bechini A, Ricciardi W, DE Waure C, Marcellusi A, Cicchetti A, Ruggeri M, Boccalini S.

J Prev Med Hyg. 2015;56(4):E150-4.

13.

Development and preliminary data on the use of a mobile app specifically designed to increase community awareness of invasive pneumococcal disease and its prevention.

Panatto D, Domnich A, Gasparini R, Bonanni P, Icardi G, Amicizia D, Arata L, Bragazzi NL, Signori A, Landa P, Bechini A, Boccalini S.

Hum Vaccin Immunother. 2016 Apr 2;12(4):1080-4. doi: 10.1080/21645515.2015.1114196.

14.

Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: Should we expect herd protection of adults through infants' vaccination?

Azzari C, Cortimiglia M, Nieddu F, Moriondo M, Indolfi G, Mattei R, Zuliani M, Adriani B, Degl'Innocenti R, Consales G, Aquilini D, Bini G, Di Natale ME, Canessa C, Ricci S, de Vitis E, Mangone G, Bechini A, Bonanni P, Pasinato A, Resti M.

Hum Vaccin Immunother. 2016;12(2):344-50. doi: 10.1080/21645515.2015.1102811.

15.

Assessment of the effectiveness of the universal varicella vaccination program in Toscana (Italy), in the period 2010-2013.

Pieri L, Porchia BR, Pieralli F, Varone O, Niccolai G, Roselli A, Boccalini S, Bonanni P, Bechini A; Working Group of Tuscan LHU’s.; Working Group of Tuscan LHU's..

Epidemiol Prev. 2015 Jul-Aug;39(4 Suppl 1):119-23.

16.

HPV vaccination for boys? A systematic review of economic studies.

Sinisgalli E, Bellini I, Indiani L, Sala A, Bechini A, Bonanni P, Boccalini S.

Epidemiol Prev. 2015 Jul-Aug;39(4 Suppl 1):51-8.

17.

How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines.

Gasparini R, Panatto D, Bragazzi NL, Lai PL, Bechini A, Levi M, Durando P, Amicizia D.

J Immunol Res. 2015;2015:189153. doi: 10.1155/2015/189153. Review.

18.
19.

Surveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012.

Levi M, Donzellini M, Varone O, Sala A, Bechini A, Boccalini S, Bonanni P.

J Prev Med Hyg. 2014 Dec;55(4):145-51.

20.

Human papilloma virus vaccination: impact and recommendations across the world.

Bonanni P, Bechini A, Donato R, Capei R, Sacco C, Levi M, Boccalini S.

Ther Adv Vaccines. 2015 Jan;3(1):3-12. doi: 10.1177/2051013614557476. Review.

Items per page

Supplemental Content

Loading ...
Support Center